In situ expression of protooncogenes and Fas/Fas ligand in rheumatoid arthritis synovium

J Rheumatol. 1997 Mar;24(3):430-5.

Abstract

Objective: To examine the relationship among the expression of protooncogenes such as c-fos and c-myc, Fas antigen, Fas ligand, and apoptosis in the synovial tissue of patients with rheumatoid arthritis (RA).

Methods: The expression of c-fos, c-myc, Fas antigen, and Fas ligand was examined in synovial tissues of 6 patients with RA and 4 with osteoarthritis (OA) using in situ reverse transcriptase (RT) assay and immunohistochemical staining. Apoptosis was detected by TUNEL method in situ.

Results: Expression of protooncogenes, c-fos, and c-myc was detected in all samples from patients with RA, but in only a few cells of OA synovium. 30 to 90% of cells in RA synovium positive for these protooncogenes also coexpressed Fas antigen. Fas positive cells in RA synovium underwent apoptosis to a significant degree. Fas ligand mRNA was detected only in mononuclear cells in RA synovium.

Conclusion: The expression of protooncogenes is closely related to Fas mediated apoptosis in RA synoviocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Apoptosis / physiology
  • Arthritis, Rheumatoid / genetics*
  • Fas Ligand Protein
  • Female
  • Humans
  • Male
  • Membrane Glycoproteins / genetics*
  • Middle Aged
  • Proto-Oncogene Proteins c-fos / genetics*
  • Proto-Oncogene Proteins c-jun / genetics*
  • RNA, Messenger / metabolism
  • Synovial Membrane / cytology
  • Synovial Membrane / immunology
  • fas Receptor / genetics

Substances

  • FASLG protein, human
  • Fas Ligand Protein
  • Membrane Glycoproteins
  • Proto-Oncogene Proteins c-fos
  • Proto-Oncogene Proteins c-jun
  • RNA, Messenger
  • fas Receptor